LifeMatrix Technologies AG
Edit

LifeMatrix Technologies AG

http://www.lifematrixtechnologies.com/en/
Last activity: 06.05.2024
Categories: ActiveDevelopmentHardwareHumanLivingMedTechOwnProductSpaceTechnology
LifeMatrix is active in the field of medical biomimetics and has developed a unique bio-engineering technology to grow human replacement tissues in the laboratory as next generation implants for the treatment of cardiovascular diseases. The patented LifeMatrix tissues can be produced as heart valves, blood vessels and other structures. When implanted, the patient's own cells transform the LifeMatrix implants into living tissue which can grow and regenerate with the patient. LifeMatrix implants are off-the-shelf products, scalable, cost-effective, non-immunogenic and applicable to every patient. The disruptive LifeMatrix technology has the potential to overcome the significant limitations of existing implants and revolutionize the medical device industry.
Mentions
6

Investors 2

Mentions in press and media 6

DateTitleDescription
06.05.2024Innosuisse funded 45 Start-up innovation projects With the Start-up innovation project, Innosuisse directly funds high potential science-based projects initiated by Swiss start-ups, giving them a financial boost to propel their market entry. The innovation projects must be based on applic...
11.05.2022Lumiphase awarded for its breakthrough in data communication
04.04.2022Die drei Finalisten für den ZKB Pionierpreis Technopark 2022 stehen fest
10.11.2021Six Innobooster projects up for the next step
30.04.2021LifeMatrix to advance its biomimetic implants
30.04.2021LifeMatrix to advance its biomimetic implantsLifeMatrix's patented biomimetic implants are made from biodegradable polymer scaffolds shaped for various indications―such as heart valves or blood vessels―and human cells from Master Cell Banks. The latter are subsequently cultured in bio...

Reviews 0

Sign up to leave a review

Sign up Log In